
Ucoglim M 2mg/500mg Tablet SR
Marketer
Smayan Healthcare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Ucoglim M 2mg/500mg Tablet SR
Diabex Duo 2mg/500mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Diabex Duo is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) will be recommended by your doctor.
Uses of Ucoglim M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Ucoglim M 2mg/500mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Ucoglim M 2mg/500mg Extended-Release tablets with food.
Common Side effects of Ucoglim M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Ucoglim M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Ucoglim M 2mg/500mg SR Tablets. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
How Ucoglim M 2mg/500mg Tablet SR works:
Ucoglim M 2mg/500mg sustained-release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Ucoglim M 2mg/500mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Ucoglim M 2mg/500mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before use.
Breast feedingUNSAFE
Extended-release Ucoglim M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Ucoglim M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Ucoglim M 2mg/500mg SR tablets. Physician consultation is necessary. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Ucoglim M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Individuals with mild to moderate liver disease should begin treatment with a reduced Ucoglim M 2mg/500mg SR tablet dosage; its use is contraindicated in those with severe liver disease.
What if you forget to take Ucoglim M 2mg/500mg Tablet SR :
Should you forget to take your Ucoglim M 2mg/500mg SR Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.
Facts to Know About Ucoglim M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
